Sign in

CIK 0001799448 · Non-accelerated filer<br>Smaller reporting company

Aligos Therapeutics, Inc.

Sign in to watch
Ticker
ALGS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(800) 466-6059
Business address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. SC 13G Stake Amended Statement of Ownership
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 424B4 Offering Prospectus
  5. EFFECT Other Notice of Effectiveness
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. S-1 Offering Registration Statement
  9. 8-K Event Shareholder vote results
  10. 8-K/A Event Executive or director change
  11. SC 13D/A Stake Beneficial Ownership Report
  12. SC 13D/A Stake Beneficial Ownership Report
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Other disposition Director disposed of 504,081 shares (other)
  18. UPLOAD Other SEC-generated Letter
  19. DRS Other Draft Registration Statement
  20. 10-Q Report Quarterly Report

Page 14 of 18 · 348 filings